MATINAS BIOPHARMA HLDGS INC - COM (MTNB)

CUSIP: 576810105

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM
Total 13F shares
25,833,840
Share change
-750,170
Total reported value
$9,301,533
Price per share
$0.36
Number of holders
50
Value change
-$279,636
Number of buys
10
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 576810105?
CUSIP 576810105 identifies MTNB - MATINAS BIOPHARMA HLDGS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MATINAS BIOPHARMA HLDGS INC - COM (MTNB) as of Q2 2023

As of 30 Jun 2023, MATINAS BIOPHARMA HLDGS INC - COM (MTNB) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,833,840 shares. The largest 10 holders included VANGUARD GROUP INC, Sargent Investment Group, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Arkadios Wealth Advisors, NEVILLE RODIE & SHAW INC, JTC Employer Solutions Trustee Ltd, STATE STREET CORP, LPL Financial LLC, and STALEY CAPITAL ADVISERS INC. This page lists 50 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.